These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 13992475)
41. [APROPOS OF A METHOD OF OCCLUSIVE DRESSING IN THE TREATMENT OF PSORIASIS]. WORINGER F; LEVY JF; BERGOEND H Bull Soc Fr Dermatol Syphiligr; 1963; 70():233-5. PubMed ID: 14075190 [No Abstract] [Full Text] [Related]
42. Eccrine function during therapy of psoriasis. Paradoxical sweating on and around psoriatic lesions during tropical therapy by fluocinolone acetonide and plastic films. BUCK HW; MITCHELL JC Arch Dermatol; 1963 Jun; 87():696-700. PubMed ID: 14016549 [No Abstract] [Full Text] [Related]
43. Fluocinolone-plastic treatment and traditional treatment in severe psoriasis. A comparative study. Knudsen EA Acta Derm Venereol; 1965; 45(1):50-8. PubMed ID: 4163217 [No Abstract] [Full Text] [Related]
44. [Pilar pytiriasis rubra improved by applications of fluocinolone acetonide cream under occlusive dressing]. Thiers H; Colomb D; Jamain C Lyon Med; 1966 Apr; 215(17):1181-2. PubMed ID: 4222525 [No Abstract] [Full Text] [Related]
45. [COMPARATIVE STUDIES ON EXTERNAL CORTICOSTEROIDS. THE PRO AND CON OF THE ANTIBIOTIC ADDITIVE]. SIMONS RD Hautarzt; 1964 Jun; 15():287-94. PubMed ID: 14234732 [No Abstract] [Full Text] [Related]
46. A new corticoid for topical therapy. Fluocinolone acetonide. SCHOLTZ JR Calif Med; 1961 Oct; 95(4):224-6. PubMed ID: 13909153 [TBL] [Abstract][Full Text] [Related]
47. Therapy of mycosis fungoides with topically applied fluocinolone acetonide under occlusive dressing. Farber EM; Cox AJ; Steinberg J; McClintock RP Cancer; 1966 Feb; 19(2):237-45. PubMed ID: 5905467 [No Abstract] [Full Text] [Related]
48. BETAMETHASONE 17-VALERATE: A NEW TOPICAL CORTICOSTEROID. WILLIAMS DI; WILKINSON DS; OVERTON J; MILNE JA; MCKENNA WB; LYELL A; CHURCH R Lancet; 1964 May; 1(7344):1177-9. PubMed ID: 14132653 [No Abstract] [Full Text] [Related]
49. [TREATMENT OF A SERIES OF 35 STUBBORN DERMATOSES BY FLUOCINOLONE ACETONIDE IN OCCLUSIVE DRESSINGS]. SOUILLIART F Gaz Med Fr; 1965 Jan; 72():374-6. PubMed ID: 14293465 [No Abstract] [Full Text] [Related]
50. [DEVELOPMENTS IN LOCAL CORTICOSTEROID THERAPY]. LOFFERER O; GARBSCH E Med Welt; 1964 May; 18():1015-9. PubMed ID: 14237027 [No Abstract] [Full Text] [Related]
51. [Treatment of psoriasis with Synalar ointment]. Chowaniec O Przegl Dermatol; 1973; 60(2):234-8. PubMed ID: 4791679 [No Abstract] [Full Text] [Related]
56. [THERAPY OF VARIOUS TYPES OF ECZEMA WITH FLUOCINOLONE ACETONIDE HYDROPHILIC OINTMENT]. FUKUHARA M; SONODA S Hifuka Kiyo; 1963 Mar; 58():103-5. PubMed ID: 14045192 [No Abstract] [Full Text] [Related]
57. FLUOCINOLONE ACETONIDE IN AN OINTMENT BASE: A CLINICAL EVALUATION. DICK LA Skin (Los Angeles); 1963 Dec; 2():371-3. PubMed ID: 14088565 [No Abstract] [Full Text] [Related]
58. [On the effectiveness of highly concentrated fluocinolone acetonide cream in various skin diseases]. Gebhardt R; Holzmann H Med Welt; 1969 Mar; 9():484-8. PubMed ID: 5771355 [No Abstract] [Full Text] [Related]
59. [Epidermal DNA synthesis under occlusive dressings in the tritium-thymidine autoardiogram]. Born W Z Haut Geschlechtskr; 1969 May; 44(9):305-10. PubMed ID: 5772389 [No Abstract] [Full Text] [Related]